Tirzepatide (Month 1) 2.5mg
US$ 26.23
mounjaro tirzepatide injection 2.5 mg 2.5mg KwikPen Solution for Mounjaro for Type 2 Diabetes
Description
About three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and many more would like to
Tirzepatide, also known by its development code Mounjaro, is a novel investigational medication designed to address the complex challenges of type 2 diabetes mellitus (T2DM)
Each red bar quantifies the GLP-1 utilization per 1,000 Members of the plan, from a low of 1.6 in 2021 to 7.3 in 2023H1
During GGIT, semaglutide significantly increased ISR to levels similar to those in healthy participants
Newer formulations, taken as a pill rather than an injection, could be made for about $16 a month
